nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Decitabine—Gemcitabine—breast cancer	0.583	1	CrCrCtD
Telbivudine—Stavudine—SLC28A1—breast cancer	0.00554	0.372	CrCbGaD
Telbivudine—Zidovudine—SLC28A1—breast cancer	0.0022	0.148	CrCbGaD
Telbivudine—Decitabine—DNMT3A—breast cancer	0.00219	0.147	CrCbGaD
Telbivudine—Decitabine—DNMT1—breast cancer	0.00118	0.0794	CrCbGaD
Telbivudine—Zidovudine—TERT—breast cancer	0.00113	0.0759	CrCbGaD
Telbivudine—Floxuridine—TYMS—breast cancer	0.000963	0.0648	CrCbGaD
Telbivudine—Trifluridine—TYMS—breast cancer	0.000765	0.0515	CrCbGaD
Telbivudine—Zidovudine—ABCG2—breast cancer	0.000296	0.0199	CrCbGaD
Telbivudine—Cladribine—ABCG2—breast cancer	0.000208	0.014	CrCbGaD
Telbivudine—Dizziness—Thiotepa—breast cancer	0.000155	0.000384	CcSEcCtD
Telbivudine—Rash—Vinorelbine—breast cancer	0.000154	0.000384	CcSEcCtD
Telbivudine—Dermatitis—Vinorelbine—breast cancer	0.000154	0.000383	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—breast cancer	0.000154	0.000383	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—breast cancer	0.000154	0.000382	CcSEcCtD
Telbivudine—Ill-defined disorder—Capecitabine—breast cancer	0.000154	0.000382	CcSEcCtD
Telbivudine—Headache—Vinorelbine—breast cancer	0.000153	0.000381	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—breast cancer	0.000153	0.000381	CcSEcCtD
Telbivudine—Body temperature increased—Fluorouracil—breast cancer	0.000153	0.00038	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.00015	0.000373	CcSEcCtD
Telbivudine—Malaise—Capecitabine—breast cancer	0.000149	0.000371	CcSEcCtD
Telbivudine—Cough—Docetaxel—breast cancer	0.000149	0.000371	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—breast cancer	0.000149	0.000371	CcSEcCtD
Telbivudine—Insomnia—Paclitaxel—breast cancer	0.000149	0.00037	CcSEcCtD
Telbivudine—Vomiting—Thiotepa—breast cancer	0.000149	0.000369	CcSEcCtD
Telbivudine—Paraesthesia—Paclitaxel—breast cancer	0.000148	0.000367	CcSEcCtD
Telbivudine—Zidovudine—CYP3A4—breast cancer	0.000148	0.00993	CrCbGaD
Telbivudine—Rash—Thiotepa—breast cancer	0.000148	0.000366	CcSEcCtD
Telbivudine—Dermatitis—Thiotepa—breast cancer	0.000147	0.000366	CcSEcCtD
Telbivudine—Headache—Thiotepa—breast cancer	0.000147	0.000364	CcSEcCtD
Telbivudine—Arthralgia—Docetaxel—breast cancer	0.000146	0.000362	CcSEcCtD
Telbivudine—Chest pain—Docetaxel—breast cancer	0.000146	0.000362	CcSEcCtD
Telbivudine—Myalgia—Docetaxel—breast cancer	0.000146	0.000362	CcSEcCtD
Telbivudine—Nausea—Vinorelbine—breast cancer	0.000146	0.000361	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—breast cancer	0.000145	0.000361	CcSEcCtD
Telbivudine—Dyspepsia—Paclitaxel—breast cancer	0.000145	0.00036	CcSEcCtD
Telbivudine—Asthenia—Irinotecan—breast cancer	0.000145	0.00036	CcSEcCtD
Telbivudine—Asthenia—Mitoxantrone—breast cancer	0.000145	0.00036	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—breast cancer	0.000145	0.00036	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000145	0.000359	CcSEcCtD
Telbivudine—Cough—Capecitabine—breast cancer	0.000145	0.000359	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—breast cancer	0.000143	0.000356	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000142	0.000354	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000142	0.000353	CcSEcCtD
Telbivudine—Fatigue—Paclitaxel—breast cancer	0.000142	0.000353	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—breast cancer	0.000142	0.000352	CcSEcCtD
Telbivudine—Asthenia—Gemcitabine—breast cancer	0.000141	0.000351	CcSEcCtD
Telbivudine—Arthralgia—Capecitabine—breast cancer	0.000141	0.00035	CcSEcCtD
Telbivudine—Myalgia—Capecitabine—breast cancer	0.000141	0.00035	CcSEcCtD
Telbivudine—Chest pain—Capecitabine—breast cancer	0.000141	0.00035	CcSEcCtD
Telbivudine—Pain—Paclitaxel—breast cancer	0.000141	0.00035	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—breast cancer	0.000141	0.000349	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00014	0.000348	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—breast cancer	0.00014	0.000347	CcSEcCtD
Telbivudine—Discomfort—Capecitabine—breast cancer	0.000139	0.000346	CcSEcCtD
Telbivudine—Pruritus—Gemcitabine—breast cancer	0.000139	0.000346	CcSEcCtD
Telbivudine—Nausea—Thiotepa—breast cancer	0.000139	0.000345	CcSEcCtD
Telbivudine—Diarrhoea—Irinotecan—breast cancer	0.000138	0.000343	CcSEcCtD
Telbivudine—Diarrhoea—Mitoxantrone—breast cancer	0.000138	0.000343	CcSEcCtD
Telbivudine—Nervous system disorder—Docetaxel—breast cancer	0.000137	0.00034	CcSEcCtD
Telbivudine—Pruritus—Fluorouracil—breast cancer	0.000137	0.00034	CcSEcCtD
Telbivudine—Thrombocytopenia—Docetaxel—breast cancer	0.000137	0.00034	CcSEcCtD
Telbivudine—Feeling abnormal—Paclitaxel—breast cancer	0.000136	0.000337	CcSEcCtD
Telbivudine—Skin disorder—Docetaxel—breast cancer	0.000136	0.000337	CcSEcCtD
Telbivudine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000135	0.000335	CcSEcCtD
Telbivudine—Diarrhoea—Gemcitabine—breast cancer	0.000135	0.000334	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—breast cancer	0.000134	0.000334	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—breast cancer	0.000134	0.000333	CcSEcCtD
Telbivudine—Dizziness—Irinotecan—breast cancer	0.000134	0.000332	CcSEcCtD
Telbivudine—Nervous system disorder—Capecitabine—breast cancer	0.000133	0.000329	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—breast cancer	0.000133	0.000329	CcSEcCtD
Telbivudine—Diarrhoea—Fluorouracil—breast cancer	0.000132	0.000329	CcSEcCtD
Telbivudine—Thrombocytopenia—Capecitabine—breast cancer	0.000132	0.000329	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—breast cancer	0.000132	0.000328	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—breast cancer	0.000132	0.000327	CcSEcCtD
Telbivudine—Skin disorder—Capecitabine—breast cancer	0.000131	0.000326	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—breast cancer	0.00013	0.000324	CcSEcCtD
Telbivudine—Abdominal pain—Paclitaxel—breast cancer	0.00013	0.000324	CcSEcCtD
Telbivudine—Body temperature increased—Paclitaxel—breast cancer	0.00013	0.000324	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—breast cancer	0.000129	0.000321	CcSEcCtD
Telbivudine—Zidovudine—ALB—breast cancer	0.000129	0.00867	CrCbGaD
Telbivudine—Vomiting—Irinotecan—breast cancer	0.000128	0.000319	CcSEcCtD
Telbivudine—Vomiting—Mitoxantrone—breast cancer	0.000128	0.000319	CcSEcCtD
Telbivudine—Dizziness—Fluorouracil—breast cancer	0.000128	0.000318	CcSEcCtD
Telbivudine—Mediastinal disorder—Methotrexate—breast cancer	0.000128	0.000317	CcSEcCtD
Telbivudine—Rash—Mitoxantrone—breast cancer	0.000127	0.000316	CcSEcCtD
Telbivudine—Rash—Irinotecan—breast cancer	0.000127	0.000316	CcSEcCtD
Telbivudine—Dermatitis—Mitoxantrone—breast cancer	0.000127	0.000316	CcSEcCtD
Telbivudine—Dermatitis—Irinotecan—breast cancer	0.000127	0.000316	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000127	0.000316	CcSEcCtD
Telbivudine—Headache—Mitoxantrone—breast cancer	0.000127	0.000314	CcSEcCtD
Telbivudine—Headache—Irinotecan—breast cancer	0.000127	0.000314	CcSEcCtD
Telbivudine—Insomnia—Docetaxel—breast cancer	0.000126	0.000314	CcSEcCtD
Telbivudine—Paraesthesia—Docetaxel—breast cancer	0.000125	0.000311	CcSEcCtD
Telbivudine—Vomiting—Gemcitabine—breast cancer	0.000125	0.000311	CcSEcCtD
Telbivudine—Rash—Gemcitabine—breast cancer	0.000124	0.000308	CcSEcCtD
Telbivudine—Dermatitis—Gemcitabine—breast cancer	0.000124	0.000308	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—breast cancer	0.000123	0.000306	CcSEcCtD
Telbivudine—Headache—Gemcitabine—breast cancer	0.000123	0.000306	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000123	0.000306	CcSEcCtD
Telbivudine—Vomiting—Fluorouracil—breast cancer	0.000123	0.000306	CcSEcCtD
Telbivudine—Zidovudine—ABCB1—breast cancer	0.000123	0.00827	CrCbGaD
Telbivudine—Dyspepsia—Docetaxel—breast cancer	0.000123	0.000305	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—breast cancer	0.000123	0.000305	CcSEcCtD
Telbivudine—Insomnia—Capecitabine—breast cancer	0.000122	0.000304	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—breast cancer	0.000122	0.000303	CcSEcCtD
Telbivudine—Rash—Fluorouracil—breast cancer	0.000122	0.000303	CcSEcCtD
Telbivudine—Dermatitis—Fluorouracil—breast cancer	0.000122	0.000303	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—breast cancer	0.000122	0.000302	CcSEcCtD
Telbivudine—Paraesthesia—Capecitabine—breast cancer	0.000121	0.000302	CcSEcCtD
Telbivudine—Headache—Fluorouracil—breast cancer	0.000121	0.000301	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—breast cancer	0.000121	0.0003	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000121	0.000299	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—breast cancer	0.000121	0.000299	CcSEcCtD
Telbivudine—Fatigue—Docetaxel—breast cancer	0.00012	0.000299	CcSEcCtD
Telbivudine—Nausea—Irinotecan—breast cancer	0.00012	0.000298	CcSEcCtD
Telbivudine—Nausea—Mitoxantrone—breast cancer	0.00012	0.000298	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—breast cancer	0.000119	0.000297	CcSEcCtD
Telbivudine—Pain—Docetaxel—breast cancer	0.000119	0.000297	CcSEcCtD
Telbivudine—Back pain—Methotrexate—breast cancer	0.000119	0.000296	CcSEcCtD
Telbivudine—Dyspepsia—Capecitabine—breast cancer	0.000119	0.000296	CcSEcCtD
Telbivudine—Asthenia—Paclitaxel—breast cancer	0.000118	0.000294	CcSEcCtD
Telbivudine—Nausea—Gemcitabine—breast cancer	0.000117	0.00029	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000117	0.00029	CcSEcCtD
Telbivudine—Fatigue—Capecitabine—breast cancer	0.000117	0.00029	CcSEcCtD
Telbivudine—Pruritus—Paclitaxel—breast cancer	0.000117	0.00029	CcSEcCtD
Telbivudine—Pain—Capecitabine—breast cancer	0.000116	0.000287	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—breast cancer	0.000115	0.000287	CcSEcCtD
Telbivudine—Feeling abnormal—Docetaxel—breast cancer	0.000115	0.000286	CcSEcCtD
Telbivudine—Nausea—Fluorouracil—breast cancer	0.000115	0.000285	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—breast cancer	0.000114	0.000284	CcSEcCtD
Telbivudine—Gastrointestinal pain—Docetaxel—breast cancer	0.000114	0.000284	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—breast cancer	0.000113	0.000281	CcSEcCtD
Telbivudine—Diarrhoea—Paclitaxel—breast cancer	0.000113	0.00028	CcSEcCtD
Telbivudine—Back pain—Epirubicin—breast cancer	0.000112	0.000277	CcSEcCtD
Telbivudine—Feeling abnormal—Capecitabine—breast cancer	0.000111	0.000277	CcSEcCtD
Telbivudine—Malaise—Methotrexate—breast cancer	0.000111	0.000276	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—breast cancer	0.000111	0.000276	CcSEcCtD
Telbivudine—Gastrointestinal pain—Capecitabine—breast cancer	0.000111	0.000275	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—breast cancer	0.000111	0.000275	CcSEcCtD
Telbivudine—Abdominal pain—Docetaxel—breast cancer	0.00011	0.000274	CcSEcCtD
Telbivudine—Body temperature increased—Docetaxel—breast cancer	0.00011	0.000274	CcSEcCtD
Telbivudine—Dizziness—Paclitaxel—breast cancer	0.000109	0.000271	CcSEcCtD
Telbivudine—Cough—Methotrexate—breast cancer	0.000108	0.000267	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—breast cancer	0.000107	0.000266	CcSEcCtD
Telbivudine—Abdominal pain—Capecitabine—breast cancer	0.000107	0.000265	CcSEcCtD
Telbivudine—Body temperature increased—Capecitabine—breast cancer	0.000107	0.000265	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—breast cancer	0.000107	0.000265	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—breast cancer	0.000105	0.000261	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—breast cancer	0.000105	0.000261	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—breast cancer	0.000105	0.000261	CcSEcCtD
Telbivudine—Vomiting—Paclitaxel—breast cancer	0.000105	0.00026	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—breast cancer	0.000105	0.00026	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000104	0.000259	CcSEcCtD
Telbivudine—Malaise—Epirubicin—breast cancer	0.000104	0.000259	CcSEcCtD
Telbivudine—Rash—Paclitaxel—breast cancer	0.000104	0.000258	CcSEcCtD
Telbivudine—Dermatitis—Paclitaxel—breast cancer	0.000104	0.000258	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—breast cancer	0.000104	0.000258	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—breast cancer	0.000103	0.000257	CcSEcCtD
Telbivudine—Headache—Paclitaxel—breast cancer	0.000103	0.000256	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—breast cancer	0.000103	0.000255	CcSEcCtD
Telbivudine—Cough—Epirubicin—breast cancer	0.000101	0.00025	CcSEcCtD
Telbivudine—Asthenia—Docetaxel—breast cancer	0.0001	0.000249	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—breast cancer	9.91e-05	0.000246	CcSEcCtD
Telbivudine—Pruritus—Docetaxel—breast cancer	9.88e-05	0.000245	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—breast cancer	9.87e-05	0.000245	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—breast cancer	9.86e-05	0.000245	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—breast cancer	9.83e-05	0.000244	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—breast cancer	9.83e-05	0.000244	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—breast cancer	9.83e-05	0.000244	CcSEcCtD
Telbivudine—Nausea—Paclitaxel—breast cancer	9.79e-05	0.000243	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—breast cancer	9.78e-05	0.000243	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.76e-05	0.000242	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—breast cancer	9.71e-05	0.000241	CcSEcCtD
Telbivudine—Asthenia—Capecitabine—breast cancer	9.7e-05	0.000241	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—breast cancer	9.63e-05	0.000239	CcSEcCtD
Telbivudine—Pruritus—Capecitabine—breast cancer	9.57e-05	0.000238	CcSEcCtD
Telbivudine—Diarrhoea—Docetaxel—breast cancer	9.56e-05	0.000237	CcSEcCtD
Telbivudine—Cough—Doxorubicin—breast cancer	9.32e-05	0.000231	CcSEcCtD
Telbivudine—Diarrhoea—Capecitabine—breast cancer	9.25e-05	0.00023	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—breast cancer	9.24e-05	0.000229	CcSEcCtD
Telbivudine—Dizziness—Docetaxel—breast cancer	9.24e-05	0.000229	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—breast cancer	9.22e-05	0.000229	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—breast cancer	9.17e-05	0.000228	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—breast cancer	9.15e-05	0.000227	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—breast cancer	9.1e-05	0.000226	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—breast cancer	9.09e-05	0.000226	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—breast cancer	9.09e-05	0.000226	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—breast cancer	9.09e-05	0.000226	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—breast cancer	9.04e-05	0.000224	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.03e-05	0.000224	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—breast cancer	8.98e-05	0.000223	CcSEcCtD
Telbivudine—Dizziness—Capecitabine—breast cancer	8.94e-05	0.000222	CcSEcCtD
Telbivudine—Vomiting—Docetaxel—breast cancer	8.88e-05	0.000221	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—breast cancer	8.86e-05	0.00022	CcSEcCtD
Telbivudine—Rash—Docetaxel—breast cancer	8.81e-05	0.000219	CcSEcCtD
Telbivudine—Dermatitis—Docetaxel—breast cancer	8.8e-05	0.000219	CcSEcCtD
Telbivudine—Headache—Docetaxel—breast cancer	8.75e-05	0.000217	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—breast cancer	8.69e-05	0.000216	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—breast cancer	8.68e-05	0.000216	CcSEcCtD
Telbivudine—Pain—Methotrexate—breast cancer	8.61e-05	0.000214	CcSEcCtD
Telbivudine—Vomiting—Capecitabine—breast cancer	8.6e-05	0.000214	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—breast cancer	8.58e-05	0.000213	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—breast cancer	8.55e-05	0.000212	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—breast cancer	8.53e-05	0.000212	CcSEcCtD
Telbivudine—Rash—Capecitabine—breast cancer	8.53e-05	0.000212	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—breast cancer	8.52e-05	0.000212	CcSEcCtD
Telbivudine—Dermatitis—Capecitabine—breast cancer	8.52e-05	0.000212	CcSEcCtD
Telbivudine—Headache—Capecitabine—breast cancer	8.47e-05	0.00021	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—breast cancer	8.47e-05	0.00021	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—breast cancer	8.46e-05	0.00021	CcSEcCtD
Telbivudine—Nausea—Docetaxel—breast cancer	8.3e-05	0.000206	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—breast cancer	8.29e-05	0.000206	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—breast cancer	8.29e-05	0.000206	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—breast cancer	8.23e-05	0.000204	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—breast cancer	8.13e-05	0.000202	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—breast cancer	8.12e-05	0.000202	CcSEcCtD
Telbivudine—Pain—Epirubicin—breast cancer	8.06e-05	0.0002	CcSEcCtD
Telbivudine—Nausea—Capecitabine—breast cancer	8.03e-05	0.000199	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—breast cancer	7.96e-05	0.000198	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—breast cancer	7.96e-05	0.000198	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.94e-05	0.000197	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—breast cancer	7.88e-05	0.000196	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—breast cancer	7.83e-05	0.000194	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—breast cancer	7.76e-05	0.000193	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—breast cancer	7.7e-05	0.000191	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—breast cancer	7.67e-05	0.000191	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—breast cancer	7.52e-05	0.000187	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—breast cancer	7.51e-05	0.000187	CcSEcCtD
Telbivudine—Pain—Doxorubicin—breast cancer	7.45e-05	0.000185	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—breast cancer	7.45e-05	0.000185	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—breast cancer	7.45e-05	0.000185	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—breast cancer	7.22e-05	0.000179	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—breast cancer	7.18e-05	0.000178	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—breast cancer	7.13e-05	0.000177	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—breast cancer	7.12e-05	0.000177	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—breast cancer	6.89e-05	0.000171	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—breast cancer	6.89e-05	0.000171	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—breast cancer	6.89e-05	0.000171	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—breast cancer	6.76e-05	0.000168	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—breast cancer	6.66e-05	0.000166	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—breast cancer	6.66e-05	0.000165	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—breast cancer	6.45e-05	0.00016	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—breast cancer	6.4e-05	0.000159	CcSEcCtD
Telbivudine—Rash—Methotrexate—breast cancer	6.35e-05	0.000158	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—breast cancer	6.34e-05	0.000157	CcSEcCtD
Telbivudine—Headache—Methotrexate—breast cancer	6.31e-05	0.000157	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—breast cancer	6.25e-05	0.000155	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—breast cancer	6.23e-05	0.000155	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—breast cancer	6.17e-05	0.000153	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—breast cancer	5.99e-05	0.000149	CcSEcCtD
Telbivudine—Nausea—Methotrexate—breast cancer	5.98e-05	0.000149	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—breast cancer	5.96e-05	0.000148	CcSEcCtD
Telbivudine—Rash—Epirubicin—breast cancer	5.94e-05	0.000148	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—breast cancer	5.93e-05	0.000147	CcSEcCtD
Telbivudine—Headache—Epirubicin—breast cancer	5.9e-05	0.000147	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—breast cancer	5.76e-05	0.000143	CcSEcCtD
Telbivudine—Nausea—Epirubicin—breast cancer	5.6e-05	0.000139	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—breast cancer	5.54e-05	0.000138	CcSEcCtD
Telbivudine—Rash—Doxorubicin—breast cancer	5.5e-05	0.000136	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—breast cancer	5.49e-05	0.000136	CcSEcCtD
Telbivudine—Headache—Doxorubicin—breast cancer	5.46e-05	0.000136	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—breast cancer	5.18e-05	0.000129	CcSEcCtD
